Federal Register / Vol. 79, No. 211 / Friday, October 31, 2014 / Notices 64805 

size, use this information to deduce the 

identity of a particular individual). 

RETENTION AND DISPOSAL: 

CMS will retain information for a total 

period not to exceed 30 years. All 

claims-related records are encompassed 

by the document preservation order and 

will be retained until notification is 

received from DOJ. 

RETRIEVING, ACCESSING, RETAINING, AND

DISPOSING OF RECORDS IN THE SYSTEM: 

STORAGE: 

All records are stored on electronic 

media. 

RETRIEVABILITY: 

The collected data are retrieved by an 

individual identifier; e.g., beneficiary, 

recipient or provider name, HICN, or 

unique provider identification number 

(NPI). 

SAFEGUARDS: 

CMS has safeguards in place for 

authorized users and monitors such 

users to ensure against excessive or 

unauthorized use. Personnel having 

access to the system have been trained 

in the Privacy Act and information 

security requirements. Employees who 

maintain records in this system are 

instructed not to release data until the 

intended recipient agrees to implement 

appropriate management, operational 

and technical safeguards sufficient to 

protect the confidentiality, integrity and 

availability of the information and 

information systems and to prevent 

unauthorized access. 

This system will conform to all 

applicable Federal laws and regulations 

and Federal, HHS, and CMS policies 

and standards as they relate to 

information security and data privacy. 

These laws and regulations may apply 

but are not limited to: The Privacy Act 

of 1974; and the Federal Information 

Department regulation 45 CFR 5b.7. 

SYSTEM MANAGER AND ADDRESS: 

Director, Data Development and 

Services Group, Office of Information 

Products and Data Analytics (OIPDA), 

OEM, Mail Stop B2–29–04, CMS, 7500 

Security Boulevard, Baltimore, MD 

21244–1849. 

NOTIFICATION PROCEDURE: 

An individual record subject who 

wishes to know if this system contains 

records about him or her should write 

to the system manager who will require 

the system name, HICN, and for 

verification purposes, the subject 

individual’s name (woman’s maiden 

name, if applicable), and SSN 

(furnishing the SSN is voluntary, but it 

may make searching for a record easier 

and prevent delay). 

RECORD ACCESS PROCEDURE: 

An individual seeking access to 

records about him or her in this system 

should use the same procedures 

outlined in Notification Procedures 

above. The requestor should also 

reasonably specify the record contents 

being sought. (These procedures are in 

accordance with Department regulation 

45 CFR 5b.5(a)(2).) 

CONTESTING RECORD PROCEDURES: 

To contest a record, the subject 

individual should contact the system 

manager named above, and reasonably 

identify the record and specify the 

information to be contested. The 

individual should state the corrective 

action sought and the reasons for the 

correction with supporting justification. 

(These procedures are in accordance 

with Department regulation 45 CFR 

5b.7.) 

RECORDS SOURCE CATEGORIES: 

The data collected and maintained in 

this system are retrieved from the 

following databases: Medicare Drug 

Data Processing System, System No. 09– 

70–0553 (73 FR 30943 (May 29, 2008)); 

Medicare Beneficiary Database, System 

No. 09–70–0536 (71 FR 70396 

(December 4, 2006)); Medicare 

Advantage Prescription Drug System, 

System No. 09–70–0588 (76 FR 47190 

(August 4, 2011)); Medicaid Statistical 

Information System, System No. 09–70– 

0541 (71 FR 65527 (November 8, 2006)); 

Retiree Drug Subsidy Program, System 

No. 09–70–0550 (70 FR 41035 (July 15, 

2005)); Common Working File, System 

No. 09–70–0526 (71 FR 64955 

(November 6, 2006)); National Claims 

History, System No. 09–70–0558 (71 FR 

67137 11/20/2006 (November 20, 

2006)); Enrollment Database, System 

No. 09–70–0502 (73 FR 10249 2/26/ 

2008 (February 26, 2008)); Carrier 

Medicare Claims Record, System No. 

09–70–0501 (71 FR 64968 11/6/2006 

(November 6, 2006)); Intermediary 

Medicare Claims Record, System No. 

09–70–0503 (71 FR 648961 (November 

6, 2006)); Unique Physician/Provider 

Identification Number, System No. 09– 

70–0525 (71 FR 66535 (November 15, 

2006)); Medicare Supplier Identification 

File, System No. 09–70–0530 (71 FR 

70404 (December 4, 2006)), A Current 

Beneficiary Survey, System No. 09–70– 

0519 (71 FR 60722 (October 16, 2006)); 

National Plan & Provider Enumerator 

System, System No. 09–70–0555, (75 FR 

30411 (June 1, 2010)); Long Term Care 

MDS, System No. 09–70–0528 (72 FR 

12801 (March 19, 2007)); HHA Outcome 

and Assessment Information Set, 

System No. 09–70–0522 (72 FR 63906 

(November 13, 2007)); and Integrated 

Data Repository, System No. 09–70– 

0571 (71 FR 74915 (December 13, 

2006)); Provider Enrollment Chain and 

Ownership System, System No. 09–70– 

0532 (71 FR 60536 (October 13, 2006); 

Medicare and Medicaid Electronic 

Health Record (EHR) Incentive Program 

National Level Repository, System No. 

09–70–0587 (75 FR 73095 (November 

29, 2010)); Performance Measurement 

and Reporting System, System No. 09– 

70–0584 (74 FR 17672 (April 16, 2009)); 

Encounter Data System, 09–70–0506 (79 

FR 34539 (June 17, 2014)); and National 

Death Index, 09–20–0166 (49 FR 37692 

(September 25, 1984)). 

SYSTEMS EXEMPTED FROM CERTAIN PROVISIONS

OF THE ACT: 

None. 

Celeste Dade-Vinson, 

Health Insurance Specialist, Centers for 

Medicare & Medicaid Services. 

[FR Doc. 2014–25937 Filed 10–30–14; 8:45 am] 

BILLING CODE 4120–03–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2014–N–1072] 

Agency Information Collection 

Activities; Submission for Office of 

Management and Budget Review; 

Comment Request; Application for 

Participation in the Food and Drug 

Administration Commissioner’s 

Fellowship Program 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that a proposed collection of 

information has been submitted to the 

Office of Management and Budget 

(OMB) for review and clearance under 

the Paperwork Reduction Act of 1995. 

DATES: Fax written comments on the 

collection of information by December 

1, 2014. 

ADDRESSES: To ensure that comments on 

the information collection are received, 

OMB recommends that written 

comments be faxed to the Office of 

Information and Regulatory Affairs, 

OMB, Attn: FDA Desk Officer, FAX: 

202–395–7285, or emailed to oira_

submission@omb.eop.gov. All 

comments should be identified with the 

OMB control number 0910—New and 


asabaliauskas on DSK5VPTVN1PROD with NOTICES
64806 Federal Register / Vol. 79, No. 211 / Friday, October 31, 2014 / Notices 

title ‘‘Application for Participation in 

the Food and Drug Administration 

Commissioner’s Fellowship Program.’’ 

Also include the FDA docket number 

found in brackets in the heading of this 

document. 

FOR FURTHER INFORMATION CONTACT: FDA 

PRA Staff, Office of Operations, Food 

and Drug Administration, 8455 

Colesville Rd., COLE–14526, Silver 

Spring, MD 20993–0002, PRAStaff@

fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: In 

compliance with 44 U.S.C. 3507, FDA 

has submitted the following proposed 

collection of information to OMB for 

review and clearance. 

Application for Participation in the 

FDA Commissioner’s Fellowship 

Program; (OMB Control Number 0910— 

New) 

Sections 1104, 1302, 3301, 3304, 

3320, 3361, 3393, and 3394 of Title 5 of 

the United States Code authorize 

Federal Agencies to rate applicants for 

Federal jobs. Collecting applications for 

the Commissioner’s Fellowship Program 

will allow FDA’s Office of the 

Commissioner to easily and efficiently 

elicit and review information from 

students and health care professionals 

who are interested in becoming 

involved in FDA-wide activities. The 

process will reduce the time and cost of 

submitting written documentation to the 

Agency and lessen the likelihood of 

applications being misrouted within the 

Agency mail system. It will assist the 

Agency in promoting and protecting the 

public health by encouraging outside 

persons to share their expertise with 

FDA. 

In the Federal Register of August 4, 

2014 (79 FR 45196), FDA published a 

60-day notice requesting public 

comment on the proposed collection of 

information. Although one comment 

was received, it was not responsive to 

the four collection of information topics 

solicited and, therefore, will not be 

discussed in this document. 

FDA estimates the burden of this 

collection of information as follows: 

TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1

Activity/5 U.S.C. section Number of 

respondents 

Number of 

responses per 

respondent 

Total annual 

responses 

Average 

burden per 

response 

Total hours 

1104, 1302, 3301, 3304, 3320, 3361, 3393, and 3394 ....... 600 1 600 1.33 798 

Total .............................................................................. ........................ ........................ ........................ ........................ 798 

1There are no capital costs or operating and maintenance costs associated with this collection of information. 

FDA based these estimates on the 

number of inquiries that have been 

received concerning the program and 

the number of requests for application 

forms over the past 5 years. 

Dated: October 27, 2014. 

Leslie Kux, 

Assistant Commissioner for Policy. 

[FR Doc. 2014–25893 Filed 10–30–14; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2014–N–0801] 

Agency Information Collection 

Activities; Submission for Office of 

Management and Budget Review; 

Comment Request; Exports: 

Notification and Recordkeeping 

Requirements; Correction 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice; correction. 

SUMMARY: The Food and Drug 

Administration (FDA) is correcting a 

notice that appeared in the Federal 

Register of October 14, 2014. The 

document announced that a proposed 

collection of information had been 

submitted to the Office of Management 

and Budget (OMB) for review and 

clearance under the Paperwork 

Reduction Act of 1995. In this 

document, we correct some errors that 

appeared in the notice. 

FOR FURTHER INFORMATION CONTACT: FDA 

PRA Staff, Office of Operations, Food 

and Drug Administration, 8455 

Colesville Rd., COLE–14526, Silver 

Spring, MD 20993–0002, PRAStaff@

fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: In FR Doc. 

2014–24293, appearing on page 61643 

in the Federal Register of October 14, 

2014 (79 FR 61643), we make the 

following correction: On page 61644, 

replace table 1 with the following table: 

TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1

21 CFR section Number of 

respondents 

Number of 

responses per 

respondent 

Total annual 

responses 

Average 

burden per 

response 

Total hours 

1.101(d) (Non-Tobacco) (CBER) ......................................... 5 193 965 15 14,475 

1,101(d) (Non-Tobacco) (CDER) ......................................... 5 180 900 15 13,500 

1.101(d) (Non-Tobacco) (CDRH) ......................................... 63 130 8,190 15 122,850 

Total 2 ............................................................................ ........................ ........................ ........................ ........................ 150,825 

1There are no capital costs or operating and maintenance costs associated with this collection of information. 

2 Due to a clerical error, the reporting burden for ‘‘Exports: Notification and Recordkeeping Requirements’’, which published on July 3, 2014 (79 

FR 38036), was incorrect. Table 1 of this document contains the correct reporting burden for this collection. 


asabaliauskas on DSK5VPTVN1PROD with NOTICES